Navigation Links
Mindray to Report Second Quarter 2012 Financial Results on August 6, 2012

SHENZHEN, China, July 18, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the second quarter ended June 30, 2012 after the U.S. market closes on August 6, 2012. Mindray's management will hold an earnings conference call at 8:00 AM on August 7, 2012 U.S. Eastern Time (8:00 PM on August 7, 2012 Beijing/Hong Kong Time).

Dial-in details for the earnings conference call are as follows:International Toll Free:United States:

+1-866-519-4004Hong Kong:



Local dial-in numbers:United States:

+1-718-354-1231Hong Kong:

+852-2475-0994 China:


Passcode for all regions: MindrayA replay of the conference call may be accessed by phone at the following numbers until August 22, 2012.

U.S. Toll Free:

+1-866-214-5335U.S. Toll:

+1-718-354-1232China Toll:


1181-5908Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at:  

About MindrayWe are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit

For investor and media inquiries, please contact:

In the U.S.:
Hoki Luk
Western Bridge, LLC

In China:
Cathy Gao
Mindray Medical International Limited

SOURCE Mindray Medical International Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
2. Mindray Medical to Acquire Controlling Stake in Hangzhou Optcla Medical Instrument
3. Mindray Announces First Quarter 2012 Financial Results
4. Mindray Medical to Present at AACC Clinical Lab Expo 2012
5. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
6. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
11. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
Post Your Comments:
(Date:10/8/2015)... Oct. 8, 2015  Allergan plc (NYSE: AGN ... it will hold its R&D Day on November 4, ... – to 1:00 p.m. PT). The company will also ... at 9:00 a.m. ET (6:00 a.m. PT). ... --> Logo - ...
(Date:10/8/2015)... CAMBRIDGE, Mass. , Oct. 8, 2015 /PRNewswire/ ... has awarded approximately $40 million to the Broad ... whole genome sequencing of 20,000 individuals, as well ... sequencing and metabolite profiling. Trans-Omics for ... an initial step toward a larger initiative, which ...
(Date:10/8/2015)... FRANCISCO , Oct. 8, 2015  Nektar Therapeutics ... the Company,s pain and oncology portfolio during an Investor ... - 3:30 p.m. Eastern Time in New ... carcinoma.  Details of the NKTR-214 Phase 1/2 clinical program ... CD122-biased immune-stimulatory cytokine designed to preferentially stimulate the production ...
Breaking Medicine Technology:
... (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David ... be using the Roche LightCycler ® 480 System, a ... gene expression and genetic variation, in advanced cancer research. ... 480 System to support several key areas of research it ...
... 2011 /PRNewswire/ -- Royal Philips Electronics ... States availability of the Ingenia MRI system, the ... Previously available in Europe, Canada and Japan, the ... Food and Drug Administration. Driven by Philips commitment ...
Cached Medicine Technology:
(Date:10/10/2015)... ... October 10, 2015 , ... ... is pleased to be recognized by The National Law Journal for inclusion in ... 50 law firms across the United States who obtained the largest awards for ...
(Date:10/9/2015)... Los Angeles, CA (PRWEB) , ... October 09, 2015 , ... ... awareness for breast cancer victims, survivors, and the ongoing effort to find a cure. ... patients another outlet for helping women in need. With their Bra Collection Campaign, Beverly ...
(Date:10/9/2015)... ... October 09, 2015 , ... Advanced Hearing ... Tennessean's eighth annual Toast of Music City, a reader’s choice awards featuring favorite ... and cast votes for their favorite businesses in over 200 categories, including best ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Asthma and Allergy Foundation of America ... Control and Prevention (CDC) to improve the knowledge and skills of underserved adults with ... a project by the CDC and allows AAFA to continue vital efforts to educate ...
(Date:10/9/2015)... ... 09, 2015 , ... MMJ PhytoTech Limited announced that they ... airing 1st QT 2016 via the Discovery Channel. Dates and show times TBA. ... – a global leader in the field of commercializing medicinal grade cannabis. As ...
Breaking Medicine News(10 mins):
... Newsletter for Healthcare ProfessionalsVOORHEES, N.J., March 30 ... urticaria (hives) and angioedema can be challenging, ... a number of immunologic and nonimmunologic mechanisms. ... seemingly identical presentation of angioedema subtypes. It ...
... March 30 One of the longest-term survivors of ... honored today by the Mesothelioma Applied Research Foundation with ... July of 1998, in St. Charles, Missouri, then-42 year-old ... over a few digestive symptoms. Nine days later, he ...
... Indigestion, constipation can be relieved with ancient remedies, ... -- Japanese herbal medicines may help people with ... -- that don,t respond to conventional treatments, a ... these gastrointestinal "motility disorders" don,t work or cause ...
... Headline All-Day FestivalWASHINGTON, March 30 Celebrating its 30th ... National Kidney Foundation is DC,s biggest one-day rock festival ... chili cooks competing for top honors. The event is ... 9:00 p.m. at RFK Stadium Festival Grounds.For the past ...
... and Complex-Event Processing (CEP) Technologies Unified in Rx ... First Choice Professionals, LLC., today announced a partnership ... ), to provide healthcare organizations with advanced technology ... renowned healthcare integration group will combine talents with ...
... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... the new C. DIFF QUIK CHEK COMPLETE (TM) rapid ... Clostridium difficile associated disease (CDAD). This follows TECHLAB(R), ...
Cached Medicine News:
CDIs new improved Implant Stabilizer has super-soft elastic bands with lace trim....
Bras and Breast Support...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
Medicine Products: